Tuesday - August 08, 2017

MP for Reading West praises “fantastic” facilities at Baylab

Alok Sharma, the Member of Parliament for Reading West has paid a visit to Bayer to learn more about the company’s vital life science work.

 Zoom image
Alok Sharma is pictured at the skin and animal health station, next to the Baylab. With him are Dan Beety, left, and Simon Greenstreet, right.

Mr Sharma was greeted by UK/Ireland head of Communications, Simon Greenstreet, and head of Health Government & Industry Affairs, Dan Beety, who gave him an insight into the company and the environment in which it operates before taking him into the Baylab to see how it is helping to promote science skills in school pupils.

 

As well as meeting Baylab manager, Emma Schierbaum, and her team, Mr Sharma was able to take part in a supervised experiment in the laboratory.

 

After his visit, he said: “I was delighted to visit the new Bayer headquarters and to have the opportunity to experience the new Baylab. It is a fantastic facility which is already making a big difference in encouraging local school pupils to better appreciate science.

 

”On the back of my visit, I will be writing to all local schools in my constituency encouraging them to take advantage of this brilliant resource provided by Bayer.”

 

Dan Beety said: “We had a valuable discussion about Bayer’s aspirations and the vital role we play locally and nationally, demonstrating our unique contribution to Reading through the Baylab, which underlines our commitment to youth and future employment prospects in life sciences.

 

“We covered crucial topics such as how Britain can ensure patients are able to access vital medicines following Brexit and our contribution to the Government’s flagship Industrial Strategy.”

 

Simon Greenstreet added: “It was a pleasure to show Mr Sharma around our new headquarters and Baylab. It is the beginning of establishing new relationships for Bayer in the Thames Valley and to show that we are proud to contribute to growth in the Thames Valley and as part of the UK economy.”

 

Notes to editors:

Bayer: Science For A Better Life

Bayer is a global enterprise with core competencies in the Life Science fields of health care and agriculture. Its products and services are designed to benefit people and improve their quality of life. At the same time, the Group aims to create value through innovation, growth and high earning power. Bayer is committed to the principles of sustainable development and to its social and ethical responsibilities as a corporate citizen. In fiscal 2016, the Group employed around 115,200 people and had sales of EUR 46.8 billion. Capital expenditures amounted to EUR 2.6 billion, R&D expenses to EUR 4.7 billion. These figures include those for the high-tech polymers business, which was floated on the stock market as an independent company named Covestro on October 6, 2015. For more information, go to www.bayer.com.

 

Contact:
Anna Litherland, Bayer Corporate Communications
Mob: +441635563008
E-mail: anna.litherland@bayer.com

 

Bayer’s offices in the UK and Ireland are located in Reading (head office), Cambridge and Dublin. For more information, go to www.bayer.co.uk

Follow us on Twitter at: www.twitter.com/UKBayer

Follow us on Facebook  www.facebook.com/UKBayer

Follow us on YouTube at: www.youtube.com/BayerUKIre

 

Forward-Looking Statements

This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer Group or subgroup management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conformthem to future events or developments.